Rezŭm water vaporization therapy versus transurethral resection of the prostate in the management of refractory urine retention: matched pair comparative multicenter experience

Tayeb, Waseem; Azhar, Raed A.; Subahi, Mohnna; Munshi, Sameer; Qarni, Abdulrahman; Bakhsh, Abdulaziz; Sejiny, Majid; Almohaisen, Turkey; Alammari, Adel; Elkoushy, Mohamed A.

doi:10.1007/s00345-023-04739-8

World J Urol

2024

DOI: 10.1007/s00345-023-04739-8

|View full text |Cite

Rezŭm water vaporization therapy versus transurethral resection of the prostate in the management of refractory urine retention: matched pair comparative multicenter experience

Waseem Tayeb,

Raed A. Azhar,

Mohnna Subahi

et al.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2024

Publication Types

Select...

Preprint1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

References 21 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Outcomes of Rezum Water Vapor Therapy for Benign Prostate Obstruction with One-Year Follow-Up: Largest Real-World Data from Türkiye

Cakiroglu,

Acar,

Uyanık

2024

Preprint

View full text Add to dashboard Cite

OBJECTIVE: To retrospectively assess the safety and efficacy of Rezum, a promising minimally invasive treatment method for BPH, in patients treated at our clinic. METHODS: From January 1, 2022, to December 31, 2022, a cohort of 71 patients presenting with moderate to severe lower urinary tract symptoms (LUTS) associated with benign prostatic hyperplasia (BPH) was enrolled in the study. These individuals opted for Rezum therapy as their treatment approach. Primary outcome measures included the International Prostate Symptom Score (IPSS), Maximum Flow Rate (Qmax), Post-Void Residual Volume (PVR), Quality of Life (QoL), prostate volume (PV), prostate-specific antigen (PSA), and the International Index of Erectile Function (IIEF) questionnaire. RESULTS: The median age of the 71 patients was 62.1±9.3 years, with a median prostate volume of 60.4±16.6 mL. Preoperatively, IPSS was 21.9±5.2, Qmax was 9.67±3.2, QoL was 3.35±0.61, IIEF-5 was 23.9±5.4, total PSA was 2.43±1.27 ng/mL, and PVR was 177.4±216.5 mL. At the 3-month follow-up, IPSS improved to 10.1±5.6, Qmax to 24.5±3.7, QoL to 1.2±0.51, IIEF-5 to 24.5±5.4, total PSA to 1.8±0.9 ng/mL, and PVR remained at 177.4±216.5 mL. At the 12-month follow-up, IPSS was 6.0±3.1, Qmax was 18.12±3.7, QoL was 1.2±0.51, IIEF-5 was 24.5±5.4, total PSA was 1.8±0.9 ng/mL, and PVR was 24.9±25.2 mL. CONCLUSION: Rezum therapy is a safe, effective, and minimally invasive option for the treatment of men with moderate to severe lower urinary tract symptoms (LUTS).

show abstract

Outcomes of Rezum Water Vapor Therapy for Benign Prostate Obstruction with One-Year Follow-Up: Largest Real-World Data from Türkiye

Cakiroglu,

Acar,

Uyanık

2024

Preprint

View full text Add to dashboard Cite

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Rezŭm water vaporization therapy versus transurethral resection of the prostate in the management of refractory urine retention: matched pair comparative multicenter experience

Cited by 1 publication

References 21 publications

Outcomes of Rezum Water Vapor Therapy for Benign Prostate Obstruction with One-Year Follow-Up: Largest Real-World Data from Türkiye

Outcomes of Rezum Water Vapor Therapy for Benign Prostate Obstruction with One-Year Follow-Up: Largest Real-World Data from Türkiye

Contact Info

Product

Resources

About